LY 53857 | CAS#60634-51-7 | 5-HT2 serotonin receptor antagonist

MedKoo Cat#: 525549 | Name: LY 53857

Description:

WARNING: This product is for research use only, not for human or veterinary use.

LY 53857 is a potent and selective 5-HT2 serotonin receptor antagonist.

Chemical Structure

LY 53857

CAS#60634-51-7

Theoretical Analysis

MedKoo Cat#: 525549

Name: LY 53857

CAS#: 60634-51-7

Chemical Formula: C27H36N2O7

Exact Mass: 500.2523

Molecular Weight: 500.59

Elemental Analysis: C, 64.78; H, 7.25; N, 5.60; O, 22.37

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

LY 53857; LY-53857; LY53857.

IUPAC/Chemical Name

Ergoline-8-carboxylic acid, 6-methyl-1-(1-methylethyl)-, 2-hydroxy-1-methylpropyl ester, (8beta)-, (Z)-2-butenedioate (1:1) (salt)

InChi Key

DYJVZTAMQYDCLP-GQHYGYCFSA-N

InChi Code

InChI=1S/C23H32N2O3.C4H4O4/c1-13(2)25-12-16-10-21-19(18-7-6-8-20(25)22(16)18)9-17(11-24(21)5)23(27)28-15(4)14(3)26;5-3(6)1-2-4(7)8/h6-8,12-15,17,19,21,26H,9-11H2,1-5H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t14?,15?,17-,19+,21+;/m0./s1

SMILES Code

[H][C@@]1(N(C)C[C@@H](C(OC(C)C(O)C)=O)C[C@@]12[H])CC3=CN(C(C)C)C4=C3C2=CC=C4.O=C(O)/C=C\C(O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 500.59 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Polo PA, Reis RO, Cedraz-Mercez PL, Cavalcante-Lima HR, Olivares EL, Medeiros MA, Côrtes WS, Reis LC. Behavioral and neuropharmacological evidence that serotonin crosses the blood-brain barrier in Coturnix japonica (Galliformes; Aves). Braz J Biol. 2007 Feb;67(1):167-71. PubMed PMID: 17505765. 2: Ni W, Fink GD, Watts SW. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension. J Pharmacol Exp Ther. 2007 May;321(2):485-91. Epub 2007 Feb 8. PubMed PMID: 17289838. 3: Lee JK, Johnson CS, Wrathall JR. Up-regulation of 5-HT2 receptors is involved in the increased H-reflex amplitude after contusive spinal cord injury. Exp Neurol. 2007 Feb;203(2):502-11. Epub 2006 Oct 23. PubMed PMID: 17059818; PubMed Central PMCID: PMC1859857. 4: Cedraz-Mercez PL, Almeida AC, Costa-e-Sousa RH, Badauê-Passos Júnior D, Castilhos LR, Olivares EL, Marinho Júnior A, Medeiros MA, Reis LC. Influence of serotonergic transmission anD postsynaptic 5-HT2C action on the feeding behavior of Coturnix japonica (Galliformes: Aves). Braz J Biol. 2005 Nov;65(4):589-95. PubMed PMID: 16532182. 5: Ononiwu IM, Allagoa DO, Nwangwu JE, Ebong OO. Some studies on the 5-hydroxytryptamine receptors in the isolated rat uterus. Afr J Med Med Sci. 2002 Dec;31(4):361-5. PubMed PMID: 15027781. 6: Ni W, Li MW, Thakali K, Fink GD, Watts SW. The fenfluramine metabolite (+)-norfenfluramine is vasoactive. J Pharmacol Exp Ther. 2004 May;309(2):845-52. Epub 2004 Jan 29. PubMed PMID: 14752059. 7: Watts SW, Thompson JM. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat. J Pharmacol Exp Ther. 2004 Apr;309(1):165-72. Epub 2004 Jan 14. PubMed PMID: 14724222. 8: Furukawa K, Nagao K, Ishii N, Uchiyama T. Responses to serotonin (5HT) in isolated corpus cavernosum penis of rabbit. Int J Impot Res. 2003 Aug;15(4):267-71. PubMed PMID: 12934054. 9: Badauê-Passos D Jr, Ventura RR, Silva LF, Olivares EL, Reis LC. Effect of brain serotoninergic stimulation on sodium appetite of euthyroid and hypothyroid rats. Exp Physiol. 2003 Mar;88(2):251-60. PubMed PMID: 12621530. 10: Johnson KW, Nelson DL, Dieckman DK, Wainscott DB, Lucaites VL, Audia JE, Owton WM, Phebus LA. Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. Cephalalgia. 2003 Mar;23(2):117-23. PubMed PMID: 12603368. 11: McKune CM, Watts SW. Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. J Pharmacol Exp Ther. 2001 Apr;297(1):88-95. PubMed PMID: 11259531. 12: Sugimoto Y, Ohkura M, Inoue K, Yamada J. Involvement of the 5-HT(2) receptor in hyperthermia induced by p-chloroamphetamine, a serotonin-releasing drug in mice. Eur J Pharmacol. 2000 Sep 8;403(3):225-8. PubMed PMID: 10973623. 13: Shannon HE, Lutz EA. Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors. Psychopharmacology (Berl). 2000 Mar;149(1):93-7. PubMed PMID: 10789888. 14: Pertz HH, Brown AM, Gager TL, Kaumann AJ. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors. J Pharm Pharmacol. 1999 Mar;51(3):319-30. PubMed PMID: 10344634. 15: Bell AA, Butz BL, Alper RH. Cardiovascular responses produced by microinjection of serotonin-receptor agonists into the paraventricular nucleus in conscious rats. J Cardiovasc Pharmacol. 1999 Feb;33(2):175-80. PubMed PMID: 10028923. 16: Sundin L, Davison W, Forster M, Axelsson M. A role of 5-HT2 receptors in the gill vasculature of the antarctic fish Pagothenia borchgrevinki. J Exp Biol. 1998 Jul;201(Pt 14):2129-38. PubMed PMID: 9639587. 17: Gleason SD, Shannon HE. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice. Eur J Pharmacol. 1998 Jan 12;341(2-3):135-8. PubMed PMID: 9543230. 18: Bragadóttir R, Kato M, Jarkman S. Serotonin elevates the c-wave of the electroretinogram of the rabbit eye by increasing the transepithelial potential. Vision Res. 1997 Sep;37(18):2495-503. PubMed PMID: 9373681. 19: Gleason SD, Shannon HE. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology (Berl). 1997 Jan;129(1):79-84. PubMed PMID: 9122367. 20: Cushing DJ, Zgombick JM, Nelson DL, Cohen ML. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J Pharmacol Exp Ther. 1996 Jun;277(3):1560-6. PubMed PMID: 8667223.